BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
19 results:

  • 1. Association of leukemia Target Genes
    Li J; Zhang W; Liu W; Rong J; Chen Y; Gu W; Zhang W
    Cancer Genomics Proteomics; 2019; 16(5):333-344. PubMed ID: 31467227
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FUSE binding protein 1 (fubp1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    Steiner M; Schneider L; Yillah J; Gerlach K; Kuvardina ON; Meyer A; Maring A; Bonig H; Seifried E; Zörnig M; Lausen J
    PLoS One; 2019; 14(1):e0210515. PubMed ID: 30653565
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The transcriptional regulator fubp1 influences disease outcome in murine and human myeloid leukemia.
    Hoang VT; Verma D; Godavarthy PS; Llavona P; Steiner M; Gerlach K; Michels BE; Bohnenberger H; Wachter A; Oellerich T; Müller-Kuller U; Weissenberger E; Voutsinas JM; Oehler VG; Farin HF; Zörnig M; Krause DS
    Leukemia; 2019 Jul; 33(7):1700-1712. PubMed ID: 30635626
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Interplay between transcription regulators RUNX1 and fubp1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
    Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
    Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The master regulator fubp1: its emerging role in normal cell function and malignant development.
    Debaize L; Troadec MB
    Cell Mol Life Sci; 2019 Jan; 76(2):259-281. PubMed ID: 30343319
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.
    Zhang L; Liu Y; Wang M; Wu Z; Li N; Zhang J; Yang C
    J Mol Cell Biol; 2017 Dec; 9(6):477-488. PubMed ID: 29272522
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic leukemia with Alternative Splicing as a Biomarker Candidate].
    Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
    Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
    Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
    Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increase in infectivity of targeted Moloney murine leukemia virus-based gene-delivery vectors through lowering the threshold for fusion.
    Viejo-Borbolla A; Thomas P; Blair ED; Schulz TF
    J Gen Virol; 2005 Sep; 86(Pt 9):2469-2480. PubMed ID: 16099905
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
    Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
    Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of the characteristics of folate binding proteins and its relationship with expression of multidrug resistance P-glycoprotein in myelodysplastic syndromes.
    Chen J; Li R; Yan S; Li Q; Bai T; Wang S
    Chin Med J (Engl); 1998 Mar; 111(3):235-8. PubMed ID: 10374424
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.
    Duncan R; Bazar L; Michelotti G; Tomonaga T; Krutzsch H; Avigan M; Levens D
    Genes Dev; 1994 Feb; 8(4):465-80. PubMed ID: 8125259
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake.
    van der Veer LJ; Westerhof GR; Rijksen G; Schornagel JH; Jansen G
    Leuk Res; 1989; 13(11):981-7. PubMed ID: 2532692
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Binding of lectins to human leukaemic cells.
    Slesak B; Bogusławska-Jaworska J; Pejcz J; Harłozińska A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):251-9. PubMed ID: 2475405
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunologic heterogeneity of the folate-binding proteins from chronic myelogenous leukemia cells and myelofibrosis spleen.
    da Costa M; Fisher C
    J Lab Clin Med; 1981 Dec; 98(6):956-64. PubMed ID: 6947034
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The identification and measurement of a folate-binding protein in human serum by radioimmunoassay.
    da Costa M; Rothenberg SP; Fischer C; Rosenberg Z
    J Lab Clin Med; 1978 Jun; 91(6):901-7. PubMed ID: 274499
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.